Time-dependent recovery of renal impairment in patients with newly diagnosed multiple myeloma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Multiple myeloma patients with renal impairment show significant kidney function recovery within 3 months of treatment. Early treatment response may predict long-term renal prognosis.
Area Of Science
- Hematology
- Nephrology
- Oncology
Background
- Renal impairment affects 20-50% of multiple myeloma patients, indicating a poor prognosis.
- Novel antimyeloma agents show promise in improving both renal function and the disease itself.
- The precise timeline and extent of renal function recovery in multiple myeloma patients remain understudied.
Purpose Of The Study
- To investigate the time-dependent clinical course of renal function recovery in multiple myeloma patients treated with novel agents.
- To analyze the impact of early treatment response on long-term renal outcomes.
- To identify potential predictors of renal recovery in this patient population.
Main Methods
- Retrospective analysis of 234 multiple myeloma patients diagnosed and treated between January 2015 and December 2022.
- Focus on 67 patients (28.6%) with renal impairment (eGFR < 60 ml/min/1.73m²) at diagnosis.
- Evaluation of estimated glomerular filtration rate (eGFR) changes at diagnosis, 3 months, 6 months, and 1 year post-treatment initiation.
Main Results
- Median eGFR improved from 28 ml/min/1.73m² at diagnosis to 41.5 ml/min/1.73m² at 3 months (42.9% increase, p < 0.0001).
- No significant further improvement in renal function was observed at 6 months or 1 year.
- Bortezomib-containing regimens were used in approximately 90% of patients; higher serum calcium at diagnosis correlated with better renal function improvement.
Conclusions
- Treatment of multiple myeloma can lead to partial recovery of renal function.
- The treatment response within the first 3 months appears crucial for predicting renal function prognosis.
- Further research with larger cohorts is necessary to identify definitive predictive factors for renal recovery.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...